Long-acting therapies hold enormous potential, but traditional delivery technologies often fall short—limited duration, unpredictable release, high costs, and complex procedures have slowed adoption and innovation across the pharmaceutical industry. These barriers prevent proven medicines from reaching their full impact and restrict companies from delivering therapies that truly meet patient and market needs.

Hera Health Solutions is solving this problem with a nanotechnology-enabled, bioerodible drug delivery platform that is already proven and rapidly scaling. Our proprietary electrospun nanofiber manufacturing allows us to reformulate existing APIs into safe, reliable, and long-acting formats such as implants, patches, and pellets. By combining scientific rigor with scalable design, Hera empowers global pharmaceutical partners to extend treatment durations, improve efficacy, and unlock new therapeutic opportunities. As a trusted collaborator, we work side-by-side with leading pharma companies worldwide to accelerate innovation and bring the next generation of long-acting therapeutics to patients everywhere.